Norethindrone (C2277aea D8d0 4c74 8bc5 F3fc386fe8dc 01)
Jencycla Tablet
Product Images NDC 68180-877
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Jencycla (NDC 68180-877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Norethindrone (C2277aea D8d0 4c74 8bc5 F3fc386fe8dc 02)
Direction For Starting Pops (C2277aea D8d0 4c74 8bc5 F3fc386fe8dc 03)
Jencycla(norethindrone Tablets Usp)0.35 mg28 Day Regimencarton Pack:ndc: 68180-877-133 Wallets Of 28 Tablets Each (C2277aea D8d0 4c74 8bc5 F3fc386fe8dc 04)
This appears to be a label design for a pharmaceutical product. The label shows the dimensions of 38 x 60 mm and the requirement for certain information such as GTIN, S/N, EXP, and LOT to be overprinted at the plant. The label also includes a 2D data matrix and a Pharmacode Direction of 6489. The meaning of the "No Varnish Zone" and the other text is not clear.*
Jencycla(norethindrone Tablets Usp)0.35 mg28 Day Regimenwallet Pack:ndc: 68180-877-111 Wallet Of 28 Tablets (C2277aea D8d0 4c74 8bc5 F3fc386fe8dc 05)
This is a medication package insert for Jencycla, which is a brand of norethindrone tablets used for birth control. The text includes storage instructions, manufacturer and distributor information, and a diagram of the foil packaging. The package also includes a calendar and a reminder to conduct a self-breast exam.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
